Evidence map›Paper›PMID 26303087›Full record

ReviewBest practice & research. Clinical endocrinology & metabolism2015

DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease.

Jenifer P Suntharalingham, Federica Buonocore, Andrew J Duncan, John C Achermann

Open access · hybridAbstract readReview
In one paragraph

Review in Best practice & research. Clinical endocrinology & metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 224 citations in OpenAlex.

  1. Meta-analysis of the efficacy and safety of vamorolone in Duchenne muscular dystrophy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Severe neonatal presentation of Xp21 contiguous gene deletion: adrenal crisis and neuromuscular involvement.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2025
    Article
  14. Review
  15. Adrenocortical stem cells in health and disease.Nature reviews. Endocrinology · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jenifer P SuntharalinghamGenetics & Genomic Medicine, UCL Institute of Child Health, University College London, London, UK. Electronic address: j.suntharalingam@ucl.ac.uk.
Federica BuonocoreGenetics & Genomic Medicine, UCL Institute of Child Health, University College London, London, UK. Electronic address: f.buonocore@ucl.ac.uk.
Andrew J DuncanGenetics & Genomic Medicine, UCL Institute of Child Health, University College London, London, UK. Electronic address: andy.duncan@ucl.ac.uk.
John C AchermannGenetics & Genomic Medicine, UCL Institute of Child Health, University College London, London, UK. Electronic address: j.achermann@ucl.ac.uk.
University College London · GB

Funding

Wellcome Trust 098513
6 · The paper itself

Abstract

DAX-1 (NR0B1) and SF-1 (NR5A1) are two nuclear receptor transcription factors that play a key role in human adrenal and reproductive development. Loss of DAX-1 function is classically associated with X-linked adrenal hypoplasia congenita. This condition typically affects boys and presents as primary adrenal insufficiency in early infancy or childhood, hypogonadotropic hypogonadism at puberty and impaired spermatogenesis. Late onset forms of this condition and variant phenotypes are increasingly recognized. In contrast, disruption of SF-1 only rarely causes adrenal insufficiency, usually in combination with testicular dysgenesis. Variants in SF-1/NR5A1 more commonly cause a spectrum of reproductive phenotypes ranging from 46,XY DSD (partial testicular dysgenesis or reduced androgen production) and hypospadias to male factor infertility or primary ovarian insufficiency. Making a specific diagnosis of DAX-1 or SF-1 associated conditions is important for long-term monitoring of endocrine and reproductive function, appropriate genetic counselling for family members, and for providing appropriate informed support for young people.

Indexed as

Adrenal InsufficiencyDAX-1 Orphan Nuclear ReceptorGenetic Diseases, X-LinkedHumansHypoadrenocorticism, FamilialMaleMutationPhenotypeSteroidogenic Factor 1DAX-1 Orphan Nuclear ReceptorNR0B1 protein, humanNR5A1 protein, humanSteroidogenic Factor 146,XY disorders of sex developmentAddison diseaseDAX-1hypogonadotropic hypogonadismhypospadiasinfertilityprimary adrenal insufficiencyprimary ovarian insufficiencySF-1X-linked adrenal hypoplasia congenita

Identifiers

PMID26303087
PMCPMC5159745
OpenAlexW1796122241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.